Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. [electronic resource]
- American journal of medical genetics Dec 2001
- 737-44 p. digital
Publication Type: Journal Article
0148-7299
10.1002/ajmg.1610 doi
Age of Onset Alleles DNA--genetics Family Health Female Gene Frequency Haplotypes Humans Huntingtin Protein Huntington Disease--genetics Male Nerve Tissue Proteins--genetics Nuclear Proteins--genetics Pedigree Penetrance Registries Risk Trinucleotide Repeats--genetics